Page last updated: 2024-08-23

7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide and Ataxia Telangiectasia Syndrome

7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide has been researched along with Ataxia Telangiectasia Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Faller, DV; Guo, N; Vaziri, C1
Kaufmann, WK1

Reviews

1 review(s) available for 7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide and Ataxia Telangiectasia Syndrome

ArticleYear
Cell cycle checkpoints and DNA repair preserve the stability of the human genome.
    Cancer metastasis reviews, 1995, Volume: 14, Issue:1

    Topics: Animals; Ataxia Telangiectasia; Benzopyrenes; Cell Cycle; Cell Transformation, Neoplastic; Cells, Cultured; Chromosome Aberrations; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Damage; DNA Repair; Gene Expression Regulation; Genes, p53; Genome, Human; Humans; Neoplasms; Neoplasms, Radiation-Induced; Rats; Replicon; Tumor Suppressor Protein p53

1995

Other Studies

1 other study(ies) available for 7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide and Ataxia Telangiectasia Syndrome

ArticleYear
Carcinogen-induced S-phase arrest is Chk1 mediated and caffeine sensitive.
    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 2002, Volume: 13, Issue:2

    Topics: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Adenoviridae; Alkaloids; Antineoplastic Agents; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Caffeine; Carcinogens; CDC2-CDC28 Kinases; Cell Cycle Proteins; Checkpoint Kinase 1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; DNA; DNA Replication; DNA-Binding Proteins; Drug Resistance; Enzyme Activation; Enzyme Inhibitors; Genes, Dominant; Humans; Immunoblotting; Phosphorylation; Protein Kinase C; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; S Phase; Staurosporine; Tumor Cells, Cultured; Tumor Suppressor Proteins

2002